MALAT1 and COVID-19: Several populations of mature neutrophils marked by NEAT1 were also identified by Combes et al. that did not differ significantly in proportion between mild/moderate and severe disease; however, in that same study, neutrophil NEAT1 and MALAT1 were among the most significantly increased genes tracking in patients with severe versus mild/moderate COVID-19 (20).